Abstract
Triclocarban (TCC), a formerly used disinfectant, kills bacteria via an unknown mechanism of action. A structural hallmark is its N, N=-diaryl urea motif, which is also present in other antibiotics, including the recently reported small molecule PK150. We show here that, like PK150, TCC exhibits an inhibitory effect on Staphylococcus aureus menaquinone metabolism via inhibition of the biosynthesis protein demethylmenaquinone methyltransferase (MenG). However, the activity spectrum (MIC90) of TCC across a broad range of multidrug-resistant staphylococcus and enterococcus strains was much narrower than that of PK150. Accordingly, TCC did not cause an overactivation of signal peptidase SpsB, a hallmark of the PK150 mode of action. Furthermore, we were able to rule out inhibition of FabI, a confirmed target of the diaryl ether antibiotic triclosan (TCS). Differences in the target profiles of TCC and TCS were further investigated by proteomic analysis, showing complex but rather distinct changes in the protein expression profile of S. aureus. Downregulation of the arginine deiminase pathway provided additional evidence for an effect on bacterial energy metabolism by TCC.
| Original language | English |
|---|---|
| Pages (from-to) | 1-12 |
| Number of pages | 12 |
| Journal | Applied and Environmental Microbiology |
| Volume | 86 |
| Issue number | 16 |
| DOIs | |
| State | Published - 1 Aug 2020 |
| Externally published | Yes |
Keywords
- Antimicrobial agents
- Mechanisms of action
- Proteomics
- Staphylococcus aureus
- Triclocarban
- Triclosan
Fingerprint
Dive into the research topics of 'Comparative target analysis of chlorinated biphenyl antimicrobials highlights meng as a molecular target of triclocarban'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver